Skip to content

A Case Report of NMDAR Encephalopathy

A Case Report of NMDAR Encephalopathy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06915103
Enrollment
1
Registered
2025-04-08
Start date
2024-06-20
Completion date
2024-12-19
Last updated
2025-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anti-NMDA Receptor Encephalitis, Mature Teratoma, Paraneoplastic Syndromes

Keywords

Magnetic Resonance, Gynecologic Surgery

Brief summary

This case illustrates the clinical, radiologic, and histopathologic features of Anti-NMDAR encephalitis and underscores the importance of MRI in detecting ovarian teratomas when pelvic ultrasound is inconclusive.

Interventions

DIAGNOSTIC_TESTMagnetic Resonance Imaging (MRI)

A pelvic MRI with and without contrast was performed for evaluation of the ovary.

Salpingo-oophorectomy procedure was performed on the left ovary.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
34 Years to 34 Years
Healthy volunteers
No

Inclusion criteria

* Suspected Anti-NMDA Encephalitis

Exclusion criteria

* Inability to consent

Design outcomes

Primary

MeasureTime frameDescription
Anti-NMDA Encephalitis1 weekDiagnosis of Anti-NMDA Encephalitis based on pelvic MRI

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026